自闭症谱系障碍的神经解剖内表型及其与精神分裂症和一般人群特征的关联评估
该横断面研究利用半监督机器学习方法,在ABIDE数据集307例ASD患者和362名典型发育对照的T1加权脑MRI上识别出三维神经解剖维度,并在精神分裂症队列和UK Biobank一般人群中验证。研究发现三个维度分别类似衰老、类似精神分裂症和典型ASD,其中A2维度与精神分裂症在遗传和神经解剖上部分重叠,提示两种诊断可能存在共同生物学机制。
要点
- ASD神经解剖异质性可归纳为三个维度:A1衰老样、A2精神分裂症样和A3典型ASD。
- A2维度与精神分裂症在遗传和神经解剖特征上部分重叠,且抗精神病药使用关联显著。
- A2维度在一般人群中显示显著遗传力估计,支持其作为内表型的潜在价值。
核心结论
- 研究发现ASD的三维内表型表征,可能阐明ASD异质性神经生物学基础以支持精准诊断。
- A2维度与精神分裂症显著对应,提示两种精神健康诊断可能识别出共同生物学机制。
研究设计与样本
- 横断面研究,发现队列为ABIDE多站点影像数据,包含307例16-64岁ASD患者和362名年龄性别匹配的典型发育对照。
- 使用半监督判别分析模型训练于T1加权脑MRI,并进行广泛交叉验证测试可重复性。
主要发现
- 三维方案最能捕获ASD神经解剖特征。
- A1维度与较小脑体积、较低认知功能和衰老相关遗传变异(FOXO3;Z=4.65;P=1.62×10-6)相关。
- A2维度以皮质下体积增大、抗精神病药物使用(Cohen d=0.65;FDR校正P=.048)为特征,与精神分裂症部分重叠遗传和神经解剖特征。
- A2维度在一般人群中遗传力估计显著(平均[SD] h2=0.71[0.04];P<1×10-4)。
- A3维度以皮质体积增大、高非言语认知表现和涉及脑发育与异常凋亡的生物学通路为特征(平均[SD] β=0.83[0.02];P=4.22×10-6)。
临床怎么用
- 神经解剖维度可能有助于ASD的精准诊断和异质性理解。
- A2维度与精神分裂症的对应提示跨诊断共同生物学机制,可能指导治疗开发。
局限性
- 横断面设计不能推断因果关系。
- 发现队列年龄范围为16-64岁,结果可能不适用于儿童或老年人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Autism spectrum disorder (ASD) is associated with significant clinical, neuroanatomical, and genetic heterogeneity that limits precision diagnostics and treatment. OBJECTIVE: To assess distinct neuroanatomical dimensions of ASD using novel semisupervised machine learning methods and to test whether the dimensions can serve as endophenotypes also in non-ASD populations. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used imaging data from the publicly available Autism Brain Imaging Data Exchange (ABIDE) repositories as the discovery cohort. The ABIDE sample included individuals diagnosed with ASD aged between 16 and 64 years and age- and sex-match typically developing individuals. Validation cohorts included individuals with schizophrenia from the Psychosis Heterogeneity Evaluated via Dimensional Neuroimaging (PHENOM) consortium and individuals from the UK Biobank to represent the general population. The multisite discovery cohort included 16 internationally distributed imaging sites. Analyses were performed between March 2021 and March 2022. MAIN OUTCOMES AND MEASURES: The trained semisupervised heterogeneity through discriminative analysis models were tested for reproducibility using extensive cross-validations. It was then applied to individuals from the PHENOM and the UK Biobank. It was hypothesized that neuroanatomical dimensions of ASD would display distinct clinical and genetic profiles and would be prominent also in non-ASD populations. RESULTS: Heterogeneity through discriminative analysis models trained on T1-weighted brain magnetic resonance images of 307 individuals with ASD (mean [SD] age, 25.4 [9.8] years; 273 [88.9%] male) and 362 typically developing control individuals (mean [SD] age, 25.8 [8.9] years; 309 [85.4%] male) revealed that a 3-dimensional scheme was optimal to capture the ASD neuroanatomy. The first dimension (A1: aginglike) was associated with smaller brain volume, lower cognitive function, and aging-related genetic variants (FOXO3; Z = 4.65; P = 1.62 × 10-6). The second dimension (A2: schizophrenialike) was characterized by enlarged subcortical volumes, antipsychotic medication use (Cohen d = 0.65; false discovery rate-adjusted P = .048), partially overlapping genetic, neuroanatomical characteristics to schizophrenia (n = 307), and significant genetic heritability estimates in the general population (n = 14 786; mean [SD] h2, 0.71 [0.04]; P < 1 × 10-4). The third dimension (A3: typical ASD) was distinguished by enlarged cortical volumes, high nonverbal cognitive performance, and biological pathways implicating brain development and abnormal apoptosis (mean [SD] β, 0.83 [0.02]; P = 4.22 × 10-6). CONCLUSIONS AND RELEVANCE: This cross-sectional study discovered 3-dimensional endophenotypic representation that may elucidate the heterogeneous neurobiological underpinnings of ASD to support precision diagnostics. The significant correspondence between A2 and schizophrenia indicates a possibility of identifying common biological mechanisms across the 2 mental health diagnoses.
引用
- Hwang G, Wen J, Sotardi S, et al. Assessment of Neuroanatomical Endophenotypes of Autism Spectrum Disorder and Association With Characteristics of Individuals With Schizophrenia and the General Population. JAMA Psychiatry. 2023. PMID: 37017948. doi:10.1001/jamapsychiatry.2023.0409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。